Home › Lewy Body Dementia › Pennsylvania
Lewy Body Dementia clinical trials in Pennsylvania
3 studies for Lewy Body Dementia are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Pennsylvania Hospital, Philadelphia
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595Biofluid Research on Age-Related or Inherited Neurodegeneration
- University of Pennsylvania, Philadelphia
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT07798700UPenn Observational Research Repository on Neurodegenerative Disease
- University of Pennsylvania, Philadelphia
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jan 22, 2026 · NCT04715399From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.